SCHEMBL400289

SCHEMBL400289

CC(=CCCc1ccc(O)c(O)c1)C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
MAPT P10636 6/20 0.50
HIF1A Q16665 4/20 0.50
HSD17B10 Q99714 4/20 0.50
ALDH1A1 P00352 4/20 0.50
PTGS1 P23219 3/20 0.50
LMNA P02545 3/20 0.50
BLM P54132 3/20 0.50
HPGD P15428 2/20 0.50
IAPP P10997 3/20 0.47
ALOX15 P16050 4/20 0.47
RECQL P46063 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
MAPK1 P28482 3/20 0.47
ADRA2A P08913 2/20 0.47
DRD2 P14416 2/20 0.47
DRD1 P21728 2/20 0.47
DRD4 P21917 2/20 0.47
DRD5 P21918 2/20 0.47
SLC6A2 P23975 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29655817 1.00 KDM4E (0.50) KDM4EMAPTHIF1AHSD17B10ALDH1A1
SCHEMBL29764187 0.91 ALOX15 (0.51) KDM4EMAPTHIF1AHSD17B10ALDH1A1
SCHEMBL22798842 0.86 KDM4E (0.51) KDM4EMAPTHIF1AHSD17B10ALDH1A1
SCHEMBL22798841 0.86 KDM4E (0.51) KDM4EMAPTHIF1AHSD17B10ALDH1A1
SCHEMBL339754 0.84 XDH (0.49) KDM4EMAPTHIF1AHSD17B10ALDH1A1
SCHEMBL339752 0.84 XDH (0.49) KDM4EMAPTHIF1AHSD17B10ALDH1A1
SCHEMBL1027806 0.77 GRIK1 (0.50) ALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL22799190 0.75 COPS5 (0.38) KDM4EMAPTHSD17B10BLMHPGD
SCHEMBL31230163 0.75 COPS5 (0.38) KDM4EMAPTHSD17B10BLMHPGD
Dopamine SCHEMBL28657094 0.75 KDM4E (0.78) KDM4EMAPTHIF1AHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114524951-B Polydopamine drug delivery carrier and application thereof 温州医科大学附属眼视光医院 2023-11-21 CN disclosed
CN-107532050-B Pressure sensitive adhesive for transdermal drug delivery 诺芬药品公司 2021-03-02 CN disclosed
US-10406116-B2 Pressure-sensitive adhesives for transdermal drug delivery NOVEN PHARMACEUTICALS, INC. (US) 2019-09-10 US disclosed
US-10406115-B2 Pressure-sensitive adhesives for transdermal drug delivery NOVEN PHARMACEUTICALS, INC. (US) 2019-09-10 US disclosed
EP-3506889-A1 PRESSURE-SENSITIVE ADHESIVES FOR TRANSDERMAL DRUG DELIVERY Noven Pharmaceuticals, INC. (US) 2019-07-10 EP disclosed
US-10177383-B2 Nano-coating material, method for manufacturing same, coating agent, functional material, and method for manufacturing same NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) 2019-01-08 US disclosed
WO-2018026759-A1 PRESSURE-SENSITIVE ADHESIVES FOR TRANSDERMAL DRUG DELIVERY NOVEN PHARMACEUTICALS, INC. (US) 2018-02-08 WO disclosed
CN-107532050-A Contact adhesive for cutaneous penetration 诺芬药品公司 2018-01-02 CN disclosed
US-20170214047-A1 NANO-COATING MATERIAL, METHOD FOR MANUFACTURING SAME, COATING AGENT, FUNCTIONAL MATERIAL, AND METHOD FOR MANUFACTURING SAME NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) 2017-07-27 US disclosed
US-20170129999-A1 PH Responsive Self-Healing Hydrogels Formed By Boronate-Catechol Complexation NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2017-05-11 US disclosed
US-20120329882-A1 pH Responsive Self-Heating Hydrogels Formed By Boronate-Catechol Complexation NORTHWESTERN UNIVERSITY (US) 2012-12-27 US disclosed
WO-2012159106-A2 PH RESPONSIVE SELF-HEALING HYDROGELS FORMED BY BORONATE-CATECHOL COMPLEXATION NORTHWESTERN UNIVERSITY (US) 2012-11-22 WO disclosed
US-20120157602-A1 COPOLYMERS HAVING ZWITTERIONIC MOIETIES AND DIHDROXYPHENYL MOIETIES AND MEDICAL DEVICES COATED WITH THE COPOLYMERS ABBOTT LABORATORIES (US) 2012-06-21 US disclosed
US-8202956-B2 Copolymers having zwitterionic moieties and dihydroxyphenyl moieties and medical devices coated with the copolymers ABBOTT LABORATORIES (US) 2012-06-19 US disclosed
US-8101156-B2 Methods of manufacturing copolymers with zwitterionic moieties and dihydroxyphenyl moieties and use of same ABBOTT LABORATORIES (US) 2012-01-24 US disclosed
US-20110166250-A1 COPOLYMERS HAVING ZWITTERIONIC MOIETIES AND DIHYDROXYPHENYL MOIETIES AND MEDICAL DEVICES COATED WITH THE COPOLYMERS ABBOTT LABORATORIES (US) 2011-07-07 US disclosed
US-20110160382-A1 COPOLYMERS HAVING ZWITTERIONIC MOIETIES AND DIHDROXYPHENYL MOIETIES AND MEDICAL DEVICES COATED WITH THE COPOLYMERS ABBOTT LABORATORIES (US) 2011-06-30 US disclosed
US-7928176-B2 Copolymers having zwitterionic moieties and dihydroxyphenyl moieties and medical devices coated with the copolymers ABBOTT LABORATORIES (US) 2011-04-19 US disclosed
US-20080153923-A1 Biocompatible polymer; copolymerize a dihydroxyphenyl monomer with acrylate comonomer to yield intermediate polymer; coupling zwitterionic phosphorylcholine to the acrylate comonomer of intermediate product to yield a thermoplastic polymer; improved adhesion to surface of implantable medical device ABBOTT LABORATORIES (US) 2008-06-26 US disclosed
US-20080139746-A1 Polymer preferably includes methacryloyloxyethyl phosphorylcholine, and a cationic monomer, a monomer with a pendant hydrocarbon group or a monomer with a pendant hydrophilic group; blends with polyvinylpyrrolidone, a polyacrylate or terpolymer; improved adhesion, primers not needed; stent coatings ABBOTT LABORATORIES (US) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153923-A1 Biocompatible polymer; copolymerize a dihydroxyphenyl monomer with acrylate comonomer to yield intermediate polymer; coupling zwitterionic phosphorylcholine to the acrylate comonomer of intermediate product to yield a thermoplastic polymer; improved adhesion to surface of implantable medical device CAD, PHOSPHO1, CD14 KDM4E 2706/4885MAPT 1613/4885HIF1A 2628/4885
US-20170129999-A1 PH Responsive Self-Healing Hydrogels Formed By Boronate-Catechol Complexation DBH, BAP1, APEX1 KDM4E 1114/4885MAPT 3929/4885HIF1A 400/4885
US-20120329882-A1 pH Responsive Self-Heating Hydrogels Formed By Boronate-Catechol Complexation DBH, BAP1, HAO2 KDM4E 1243/4885MAPT 3539/4885HIF1A 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.